Literature DB >> 1756199

Haloperidol and soluble interleukin-2 receptors.

M H Rapaport, A R Doran, D L Nelson, C McAllister, J R Magliozzi, S M Paul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1756199     DOI： 10.1016/0006-3223(91)90127-8

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  5 in total

1.  Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia.

Authors:  N Müller; M Empl; M Riedel; M Schwarz; M Ackenheil
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

2.  Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins.

Authors:  M H Rapaport; E F Torrey; C G McAllister; D L Nelson; D Pickar; S M Paul
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

3.  Serial mitogen-stimulated cytokine production from continuously ill patients with schizophrenia.

Authors:  Mark H Rapaport; Catherine Bresee
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

4.  Preoperative protein profiles in cerebrospinal fluid in elderly hip fracture patients at risk for delirium: A proteomics and validation study.

Authors:  Dunja Westhoff; Joost Witlox; Corneli van Aalst; Rikie M Scholtens; Sophia E de Rooij; Barbara C van Munster; Jos F M de Jonghe; Alexander P J Houdijk; Piet Eikelenboom; David J van Westerloo; Diederik van de Beek; Willem A van Gool; Leo Koenderman
Journal:  BBA Clin       Date:  2015-10-28

5.  Preoperative cerebrospinal fluid cytokine levels and the risk of postoperative delirium in elderly hip fracture patients.

Authors:  Dunja Westhoff; Joost Witlox; Leo Koenderman; Kees J Kalisvaart; Jos F M de Jonghe; Mireille F M van Stijn; Alexander P J Houdijk; Inge C M Hoogland; Alasdair M J Maclullich; David J van Westerloo; Diederik van de Beek; Piet Eikelenboom; Willem A van Gool
Journal:  J Neuroinflammation       Date:  2013-10-07       Impact factor: 8.322
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.